Top Biomaterials Companies

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Top Players Company Profiles

• BASF SE (Germany)

• Covestro AG (Germany)

• Carpenter Technology Corporation (US)

• DSM (Netherlands)

• Corbion NV (Netherlands)

• Evonik Industries AG (Germany)

• Victrex Plc (UK)

• CoorsTek Inc. (US)

• Berkeley Advanced Biomaterials (US)

• CAM Bioceramics B.V. (Netherlands)

• GELITA AG (Germany)

Recent Developments in Biomaterials Market

• In July 2024, in developing a new vascular graft based on biomaterials, Medtronic aims at enhancing the long-lasting use of the graft in the case of patients suffering peripheral artery disease. This innovation is evidence to the fact that Medtronic is committed towards creating cardiovascular biomaterials for better patient care and wider range of biomaterials’ products.

• In May 2024, Zimmer Biomet introduced an innovative orthopaedic implant made from an exclusive, highly porous titanium biomaterial. This advancement further bolsters Zimmer Biomet’s position as a leader in orthopaedic biomaterials while reaffirming its commitment to providing advanced solutions for musculoskeletal health. The purpose of this discovery is to enhance osseointegration and long-term implant stability in joint replacement surgeries.

• In March 2024, The Stryker Corporation brought forth innovation with a new biodegradable polymer implant for soft tissue healing targeted at sports medicine. The implant serves as a long-lasting therapy for patients by stimulating natural recoveries of their body cells. Such a rationale is in line with Stryker's intentions of diversifying its collection of bio-materials in response to the growing field on sports health.